– Reuters Citing Sources
A Look Into AstraZeneca’s Debt
Shares of AstraZeneca Inc. (NASDAQ:AZN) rose by 10.39% in the past three months. When understanding a companies price…
Related Posts
Assembly Biosciences Presents New Data Highlighting Entry Inhibitor And Core Inhibitor Programs At European Association For The Study Of The Liver International Liver Congress, On June 21-24, 2023
Assembly Biosciences, Inc. (NASDAQ:ASMB), a biotechnology company developing innovative antiviral therapeutics targeting serious viral diseases, today announced data from its hepatitis D virus (HDV) and hepatitis B
Berry Global Group Q1 Adj EPS $1.30 Beats $1.28 Estimate, Sales $3.06B Miss $3.34B Estimate
Berry Global Group (NYSE:BERY) reported quarterly adjusted earnings of $1.30 per share which beat the analyst consensus estimate of $1.28 by 1.56 percent. This is a 4 percent increase over earnings of $1.25 per share
Viatris To Divest OTC, Women’s Healthcare, And API Businesses In Strategic Move, For Up To $6.94B Of Total Gross Proceeds
Total Gross Proceeds From All Divestitures, Including the 2022 Divestiture of the Company's Biosimilars Business, and the Estimated Retained Value are in Line with the Company's Previously Communicated